Gain Therapeutics is trading 10.84% higher at $1.32 on October 22, 2026, with no clear company-specific catalyst identified.

  • Company announcements surfaced in search were dated October 1 and October 8.
  • The Fly listed a BTIG price-target reduction on October 22, but available reporting does not explain the move; the reduction alone does not establish a reason for the gain.
  • Broader markets were lower, offering no explanation for the positive move.